Ambros Reinhard J.

CIK 00017096901 companyAUSTIN, TX

SEC Profile

Transactions

Companies

Filings

CIK

0001709690

Recent Transactions

20 trades

Award
Rein Therapeutics, Inc.$RNTX
Stock Option (right to buy)
2025-07-23+17,500→ 17,500 total
Award
Rein Therapeutics, Inc.$RNTX
Stock Option (right to buy)
2024-12-02+35,000→ 35,000 total
Award
Rein Therapeutics, Inc.$RNTX
Stock Option (right to buy)
2024-08-20+2,725→ 2,725 total
Award
Rein Therapeutics, Inc.$RNTX
Stock Option (right to buy)
2024-02-28+2,725→ 2,725 total
Award
Rein Therapeutics, Inc.$RNTX
Stock Option (right to buy)
2024-02-28+2,725→ 2,725 total
Award
Rein Therapeutics, Inc.$RNTX
Stock Option (right to buy)
2022-06-15+54,500→ 54,500 total
Award
Rein Therapeutics, Inc.$RNTX
Stock Option (right to buy)
2021-06-15+96,000→ 96,000 total
Award
Rein Therapeutics, Inc.$RNTX
Stock Option (right to buy)
2020-06-17+12,500→ 12,500 total
Purchase
Rein Therapeutics, Inc.$RNTX
Common Stock
2020-06-15$1.22/sh+5,800→ 5,800 total
Award
Rein Therapeutics, Inc.$RNTX
Stock Option (right to buy)
2019-06-19+50,000→ 50,000 total
Award
Rein Therapeutics, Inc.$RNTX
Stock Option (right to buy)
2018-06-21+10,000→ 10,000 total
Award
Rein Therapeutics, Inc.$RNTX
Stock Option (right to buy)
2017-09-26+20,000→ 20,000 total
Conversion
Rein Therapeutics, Inc.$RNTX
Series E-2 Preferred Stock
2017-07-05−2,644,558→ 0 total
Conversion
Rein Therapeutics, Inc.$RNTX
Series F Preferred Stock
2017-07-05−3,705,882→ 0 total
Conversion
Rein Therapeutics, Inc.$RNTX
Common Stock
2017-07-05+2,277,515→ 2,277,515 total
Purchase
Rein Therapeutics, Inc.$RNTX
Common Stock
2017-07-05$15.00/sh+266,667→ 2,544,182 total
Conversion
Rein Therapeutics, Inc.$RNTX
Series D Preferred Stock
2017-07-05−6,781,770→ 0 total
Conversion
Rein Therapeutics, Inc.$RNTX
Series E-3 Preferred Stock
2017-07-05−2,293,829→ 0 total
Conversion
Rein Therapeutics, Inc.$RNTX
Series C-2 Preferred Stock
2017-07-05−4,238,607→ 0 total
Conversion
Rein Therapeutics, Inc.$RNTX
Series C Preferred Stock
2017-07-05−2,967,025→ 0 total

Companies

Rein Therapeutics, Inc.
Director
$RNTX

Recent Filings

Address

C/O REIN THERAPEUTICS, INC 12407 N. MOPAC EXPY. SUITE 250 #390

AUSTIN, TX, 78758

View on SEC.gov